InvestorsHub Logo

JustAguy22

02/13/20 10:54 PM

#56611 RE: Blane #56610

I've been Investing in this company for over 5 years, so I'm well aware. My analogy was simplistic. I'll try another. I own a 100 million dollar a year business .

I have employees that look to me to set expectations about the future. I NEVER set the best case scenario for any situation, as there are always delays.

This transparency you speak of is more accurately described as lack of experience.

New leaders want to dessiminate potentially good news for the short term positive reaction. While experienced leaders know that when you set expectations and then beat them you build trust. If you don't agree, find the most successful business person you know and ask them. I promise they will agree with me.

It's this inexperience of Nadars that concerns me the most.

weasel6667

02/14/20 3:20 AM

#56618 RE: Blane #56610

I get your point, but my wife is not an emerging biotech with multiple factors involved, so your comparison is very limited. And like I said before, the only reason anyone knows of delays is because Nader is transparent. Another thing is that if you look at where the company was 5 years ago, you’d see that it is on the cusp of getting to the finish line. It may be slow and not as fast as Nader or ya would like, but if you want a company with all hype and no forward momentum in the biotech arena, look at Regen Biopharma. Ee-gads.



.. and that is exactly the point. Why does Nader announce on a regular basis the BLA submission date which is not predictable?
At least after the second time he missed the self-imposed deadline he should start thinking. He is the CEO of the company and this does not help his credibility.
How does it help the SP when he sets those deadlines? There is no benefit to the SP and looking in the mirror, the SP went always down when he misses the deadlines ...